Mimma Formica

Mimma Formica, PharmD, RPh, is a highly experienced professional in pharmacovigilance and drug safety, currently serving as the Director of Pharmacovigilance Safety Scientist/Operations Lead at Kura Oncology, Inc. since February 2025. Previously, Mimma held the position of Director, Drug Safety & Pharmacovigilance at Sage Therapeutics, contributing to the successful NDA filing and approval of Zurzuvae®, a groundbreaking treatment for postpartum depression. Additional roles include Associate Director positions at Genmab and Kyowa Kirin, where Mimma played key roles in safety surveillance and regulatory document management. With a solid foundation in pharmacy and biological sciences from Long Island University, Rutgers University, and The University of Kansas, Mimma has a proven track record of compliance and operational excellence in various pharmaceutical settings.